• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综述天然产物靶向肿瘤免疫微环境治疗肺癌。

A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer.

机构信息

Department of Traditional Chinese Medicine, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, China.

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

出版信息

Front Immunol. 2024 Feb 1;15:1343316. doi: 10.3389/fimmu.2024.1343316. eCollection 2024.

DOI:10.3389/fimmu.2024.1343316
PMID:38361933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10867126/
Abstract

Lung cancer (LC) produces some of the most malignant tumors in the world, with high morbidity and mortality. Tumor immune microenvironment (TIME), a component of the tumor microenvironment (TME), are critical in tumor development, immune escape, and drug resistance. The TIME is composed of various immune cells, immune cytokines, etc, which are important biological characteristics and determinants of tumor progression and outcomes. In this paper, we reviewed the recently published literature and discussed the potential uses of natural products in regulating TIME. We observed that a total of 37 natural compounds have been reported to exert anti-cancer effects by targeting the TIME. In different classes of natural products, terpenoids are the most frequently mentioned compounds. TAMs are one of the most investigated immune cells about therapies with natural products in TIME, with 9 natural products acting through it. 17 natural products exhibit anti-cancer properties in LC by modulating PD-1 and PD-L1 protein activity. These natural products have been extensively evaluated in animal and cellular LC models, but their clinical trials in LC patients are lacking. Based on the current review, we have revealed that the mechanisms of LC can be treated with natural products through TIME intervention, resulting in a new perspective and potential therapeutic drugs.

摘要

肺癌(LC)是世界上最恶性的肿瘤之一,具有高发病率和死亡率。肿瘤免疫微环境(TIME)是肿瘤微环境(TME)的组成部分,在肿瘤发展、免疫逃逸和耐药性方面起着关键作用。TIME 由各种免疫细胞、免疫细胞因子等组成,是肿瘤进展和结局的重要生物学特征和决定因素。本文综述了近期发表的文献,讨论了天然产物在调节 TIME 方面的潜在用途。我们观察到,共有 37 种天然化合物被报道通过靶向 TIME 发挥抗癌作用。在不同类别的天然产物中,萜类化合物是被提及最多的化合物。TAMs 是研究天然产物在 TIME 中治疗作用最广泛的免疫细胞之一,有 9 种天然产物通过它发挥作用。17 种天然产物通过调节 PD-1 和 PD-L1 蛋白活性在 LC 中表现出抗癌特性。这些天然产物已经在动物和细胞 LC 模型中进行了广泛评估,但在 LC 患者中的临床试验却缺乏。基于目前的综述,我们已经揭示了通过 TIME 干预可以用天然产物治疗 LC 的机制,为新的视角和潜在的治疗药物提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd07/10867126/d34b872612c7/fimmu-15-1343316-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd07/10867126/e56387a8af23/fimmu-15-1343316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd07/10867126/43c8d61ed616/fimmu-15-1343316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd07/10867126/fb40e933a123/fimmu-15-1343316-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd07/10867126/ad68f054960b/fimmu-15-1343316-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd07/10867126/d34b872612c7/fimmu-15-1343316-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd07/10867126/e56387a8af23/fimmu-15-1343316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd07/10867126/43c8d61ed616/fimmu-15-1343316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd07/10867126/fb40e933a123/fimmu-15-1343316-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd07/10867126/ad68f054960b/fimmu-15-1343316-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd07/10867126/d34b872612c7/fimmu-15-1343316-g005.jpg

相似文献

1
A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer.综述天然产物靶向肿瘤免疫微环境治疗肺癌。
Front Immunol. 2024 Feb 1;15:1343316. doi: 10.3389/fimmu.2024.1343316. eCollection 2024.
2
Natural compounds: A new perspective on targeting polarization and infiltration of tumor-associated macrophages in lung cancer.天然化合物:一种靶向肺癌相关巨噬细胞极化和浸润的新视角。
Biomed Pharmacother. 2022 Jul;151:113096. doi: 10.1016/j.biopha.2022.113096. Epub 2022 May 11.
3
Natural products: Potential targets of TME related long non-coding RNAs in lung cancer.天然产物:TME 相关长非编码 RNA 作用于肺癌的潜在靶点。
Phytomedicine. 2021 Dec;93:153782. doi: 10.1016/j.phymed.2021.153782. Epub 2021 Sep 28.
4
Natural Products with Activity against Lung Cancer: A Review Focusing on the Tumor Microenvironment.具有抗肺癌活性的天然产物:聚焦肿瘤微环境的综述。
Int J Mol Sci. 2021 Oct 7;22(19):10827. doi: 10.3390/ijms221910827.
5
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade.肿瘤微环境在肺癌中的治疗意义:聚焦免疫检查点阻断。
Front Immunol. 2022 Jan 7;12:799455. doi: 10.3389/fimmu.2021.799455. eCollection 2021.
6
Systems pharmacology: a combination strategy for improving efficacy of PD-1/PD-L1 blockade.系统药理学:提高 PD-1/PD-L1 阻断疗效的联合策略。
Brief Bioinform. 2021 Sep 2;22(5). doi: 10.1093/bib/bbab130.
7
Single-cell RNA sequencing reveals the effects of anti-PD-L1 therapy on 3LL lung cancer model and its tumor microenvironment.单细胞 RNA 测序揭示抗 PD-L1 治疗对 3LL 肺癌模型及其肿瘤微环境的影响。
Med Oncol. 2023 Aug 31;40(10):285. doi: 10.1007/s12032-023-02156-w.
8
Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.铂类化疗联合 PD-1/PD-L1 抑制剂:临床前和临床研究及作用机制。
Expert Opin Drug Deliv. 2021 Feb;18(2):187-203. doi: 10.1080/17425247.2021.1825376. Epub 2020 Oct 5.
9
Targeting the prostate tumor microenvironment by plant-derived natural products.靶向植物源性天然产物的前列腺肿瘤微环境。
Cell Signal. 2024 Mar;115:111011. doi: 10.1016/j.cellsig.2023.111011. Epub 2023 Dec 15.
10
[Advances in the Study of Tumor-associated Macrophages in Lung Cancer].肺癌中肿瘤相关巨噬细胞的研究进展
Zhongguo Fei Ai Za Zhi. 2022 Jan 20;25(1):34-39. doi: 10.3779/j.issn.1009-3419.2021.102.49.

引用本文的文献

1
Cynaropicrin induces the apoptosis of colorectal cancer cells by elevating reactive oxygen species and activating the JNK/p38 MAPK.洋蓟苦素通过提高活性氧水平和激活JNK/p38丝裂原活化蛋白激酶诱导结肠癌细胞凋亡。
Am J Cancer Res. 2025 May 15;15(5):2140-2152. doi: 10.62347/OPNG2835. eCollection 2025.
2
Advances in Lung Cancer Treatment: Integrating Immunotherapy and Chinese Herbal Medicines to Enhance Immune Response.肺癌治疗进展:整合免疫疗法与中草药以增强免疫反应
Chin J Integr Med. 2025 May 23. doi: 10.1007/s11655-025-4134-0.
3
Dynamic Covalent Bond-Based Nanoassembly of Curcumin to Enhance the Selective Photothermal Therapy for Tumor Treatment.

本文引用的文献

1
Oridonin enhances cytotoxic activity of natural killer cells against lung cancer.冬凌草甲素增强自然杀伤细胞对肺癌的细胞毒性作用。
Int Immunopharmacol. 2023 Sep;122:110669. doi: 10.1016/j.intimp.2023.110669. Epub 2023 Jul 20.
2
Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624-mediated PD-L1 pathway.红景天苷通过 circ_0009624 介导的 PD-L1 通路抑制肺腺癌的多种致癌激活和免疫逃逸。
Thorac Cancer. 2023 Aug;14(24):2493-2503. doi: 10.1111/1759-7714.15034. Epub 2023 Jul 9.
3
Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer.
基于动态共价键的姜黄素纳米组装体用于增强肿瘤治疗的选择性光热疗法
Int J Nanomedicine. 2025 Mar 30;20:3861-3875. doi: 10.2147/IJN.S512590. eCollection 2025.
4
Current Advances in the Use of Mushrooms as Therapeutics for Lung Cancer: A Review.蘑菇作为肺癌治疗方法的当前进展:综述
Molecules. 2025 Mar 14;30(6):1322. doi: 10.3390/molecules30061322.
5
Drugging the tumor microenvironment epigenome for therapeutic interventions in NSCLC.通过药物作用于肿瘤微环境表观基因组以实现非小细胞肺癌的治疗干预
J Cancer. 2025 Feb 18;16(6):1832-1835. doi: 10.7150/jca.111023. eCollection 2025.
6
Antitumor activity of gamma-irradiated Rosa canina L. against lung carcinoma in rat model: a proposed mechanism.γ射线辐照犬蔷薇对大鼠肺癌模型的抗肿瘤活性:一种可能的机制。
BMC Complement Med Ther. 2025 Feb 28;25(1):86. doi: 10.1186/s12906-025-04813-1.
7
Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the "all-around warrior" in immunotherapy.程序性死亡受体 (PD-)1/PD-配体 (L)1 在泌尿系统癌症中的作用:免疫治疗中的“全能战士”。
Mol Cancer. 2024 Sep 2;23(1):183. doi: 10.1186/s12943-024-02095-8.
8
Natural products as promising modulators of breast cancer immunotherapy.天然产物作为有前景的乳腺癌免疫治疗调节剂。
Front Immunol. 2024 Jul 10;15:1410300. doi: 10.3389/fimmu.2024.1410300. eCollection 2024.
睡茄素A增强免疫检查点阻断剂治疗非小细胞肺癌的疗效。
Cancers (Basel). 2023 Jun 7;15(12):3089. doi: 10.3390/cancers15123089.
4
Trends in the approval of cancer therapies by the FDA in the twenty-first century.二十一世纪 FDA 批准癌症疗法的趋势。
Nat Rev Drug Discov. 2023 Aug;22(8):625-640. doi: 10.1038/s41573-023-00723-4. Epub 2023 Jun 21.
5
Bakuchiol inhibits lung cancer by modulating tumor microenvironment and the expression of PD-L1.补骨脂酚通过调节肿瘤微环境和 PD-L1 的表达抑制肺癌。
J Biochem Mol Toxicol. 2023 Sep;37(9):e23401. doi: 10.1002/jbt.23401. Epub 2023 Jun 20.
6
Oxymatrine: A current overview of its health benefits.氧化苦参碱:健康益处的最新概述。
Fitoterapia. 2023 Jul;168:105565. doi: 10.1016/j.fitote.2023.105565. Epub 2023 Jun 7.
7
Polydatin radiosensitizes lung cancer while preventing radiation injuries by modulating tumor-infiltrating B cells.虎杖苷通过调节肿瘤浸润 B 细胞来增敏肺癌并预防放射性损伤。
J Cancer Res Clin Oncol. 2023 Sep;149(12):9529-9542. doi: 10.1007/s00432-023-04762-7. Epub 2023 May 23.
8
A mast cell-related prognostic model for non-small cell lung cancer.一种用于非小细胞肺癌的肥大细胞相关预后模型。
J Thorac Dis. 2023 Apr 28;15(4):1948-1957. doi: 10.21037/jtd-23-362. Epub 2023 Apr 26.
9
The effect of ginsenoside Rg3 combined with chemotherapy on immune function in non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials.人参皂苷 Rg3 联合化疗对非小细胞肺癌免疫功能的影响:一项随机对照试验的系统评价和荟萃分析。
Medicine (Baltimore). 2023 Apr 7;102(14):e33463. doi: 10.1097/MD.0000000000033463.
10
Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC.整合 bulk 和单细胞 RNA-seq 分析鉴定出与癌症相关成纤维细胞相关的特征作为 NSCLC 免疫治疗的预后因素。
Cancer Immunol Immunother. 2023 Jul;72(7):2423-2442. doi: 10.1007/s00262-023-03428-0. Epub 2023 Apr 3.